Toward [18F]-Labeled Aryltrifluoroborate Radiotracers: In Vivo Positron Emission Tomography Imaging of Stable Aryltrifluoroborate Clearance in Mice
Authors:
- Curtis HarwigCHCurtis Harwig
- Ulrich Auf Dem KellerUKUlrich Auf Dem Keller
- Siobhan McCormickSMSiobhan McCormick
- Pamela AustinPAPamela Austin
- Christopher M. OverallCOChristopher M. Overall
- Michael J. AdamMAMichael J. Adam
- Thomas J. RuthTRThomas J. Ruth
- David M. PerrinDPDavid M. Perrin
- 14 August 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 130 (36) , 12045-12055
Abstract
The use of a boronic ester as a captor of aqueous [18F]-fluoride has been previously suggested as a means of labeling biomolecules in one step for positron emission tomography (PET) imaging. For this approach to be seriously considered, the [18F]-labeled trifluoroborate should be humorally stable such that it neither leaches free [18F]-fluoride to the bone nor accumulates therein. Herein, we have synthesized a biotinylated boronic ester that is converted to the corresponding trifluoroborate salt in the presence of aqueous [18F]-fluoride. In keeping with its in vitro aqueous kinetic stability at pH 7.5, the trifluoroborate appears to clear in vivo quite rapidly to the bladder as the stable trifluoroborate salt with no detectable leaching of free [18F]-fluoride to the bone. When this labeled biotin is preincubated with avidin, the pharmacokinetic clearance of the resulting complex is visibly altered. This work validates initial claims that boronic esters are potentially useful as readily labeled precursors to [18F]-PET reagents.Keywords
This publication has 33 references indexed in Scilit:
- Functional Imaging of Cancer with Emphasis on Molecular TechniquesCA: A Cancer Journal for Clinicians, 2007
- Molecular Imaging: The Vision and Opportunity for Radiology in the FutureRadiology, 2007
- Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and BeyondClinical Cancer Research, 2007
- 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CTJournal of Nuclear Medicine, 2007
- Design of radiolabelled ligands for the imaging and treatment of cancerMolecular BioSystems, 2006
- Metabolic biotinylation of cell surface receptors for in vivo imagingNature Methods, 2006
- Molecular Imaging in the Clinical ArenaJAMA, 2005
- Radiohalogens for imaging and therapyChemical Society Reviews, 2004
- MicroPET and Autoradiographic Imaging of Breast Cancer αv-Integrin Expression Using 18F- and 64Cu-Labeled RGD PeptideBioconjugate Chemistry, 2003
- Preparation and Tumor Cell Uptake of Poly(N-isopropylacrylamide) Folate ConjugatesBioconjugate Chemistry, 2002